Rbx1 Inhibitors
RBX1 inhibitors encompass a diverse group of chemicals that interact with cellular pathways, indirectly affecting the function of the RBX1 protein. This class of inhibitors does not bind directly to RBX1 but operates by modulating related pathways or processes, leading to an alteration in RBX1 activity. These chemicals exert their influence through various mechanisms, including inhibition of the proteasome, modulation of protein-protein interactions, and interference with other enzymes and proteins that are crucial for the normal functioning of RBX1.
The primary mechanism through which these chemicals act is by inhibiting proteasomal degradation. Proteasome inhibitors like MG132 and Bortezomib are quintessential examples. They prevent the breakdown of ubiquitin-tagged proteins, a process in which RBX1 is integrally involved. This inhibition results in the accumulation of these proteins within the cell, indirectly affecting the ubiquitination process that RBX1 facilitates. Another significant pathway is the modulation of neddylation. Compounds like MLN4924 and Pevonedistat target the NEDD8-activating enzyme, crucial for the neddylation of cullin proteins, which are part of the E3 ubiquitin ligase complex along with RBX1. By inhibiting this process, these chemicals indirectly disrupt the function of RBX1.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
Interacts with MDM2, a protein that works in conjunction with RBX1 in ubiquitination. It inhibits MDM2, thereby indirectly impacting RBX1 pathways. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
Inhibits NEDD8-activating enzyme, indirectly affecting the activity of RBX1 by altering the neddylation pathway which is crucial for its function. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
Similar to thalidomide, it modulates protein degradation pathways, indirectly impacting the processes where RBX1 is involved. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
An immunomodulatory drug that, like thalidomide and lenalidomide, affects protein degradation, thereby having an indirect effect on RBX1 pathways. | ||||||
CC-122 | 1015474-32-4 | sc-507488 | 5 mg | $420.00 | ||
Acts on cereblon, part of an E3 ubiquitin ligase complex, thereby influencing pathways in which RBX1 operates. | ||||||
Proteasome Inhibitor I | 158442-41-2 | sc-3127 | 1 mg | $87.00 | 1 | |
A general proteasome inhibitor that indirectly hinders RBX1 activity by blocking proteasomal degradation. | ||||||
PIK-75, hydrochloride | 372196-77-5 | sc-296089 sc-296089A | 1 mg 5 mg | $29.00 $124.00 | ||
Inhibits PI3K, indirectly affecting signaling pathways involving RBX1. | ||||||
Tozasertib | 639089-54-6 | sc-358750 sc-358750A | 25 mg 50 mg | $62.00 $87.00 | 4 | |
Inhibits Aurora kinase, indirectly impacting cellular pathways where RBX1 plays a role, particularly in cell cycle regulation. | ||||||